Visalytics
Visalytics
approved EB-2 (NIW)

Researcher

Biomedical Sciences · Taiwan · 2025-02-10

Processing Time
388 days
Decision Date
2025-02-10
Location
Wisconsin
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced genetically modified cell lines to explore the mechanisms of aging, stem cell function, and cellular reprogramming. This work focuses on creating new therapeutic pathways for infertility, neurodegeneration, and other age-related conditions to improve the well-being of the growing elderly population.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing public health challenges like neurodegeneration and infertility, which have significant socioeconomic implications for the U.S. aging population.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated readiness through a publication record of 6 articles and backing from major institutions like the Howard Hughes Medical Institute and NIH.

3 Balance of Factors to Waive Job Offer Met

The transformative nature of the biomedical advancements and the petitioner's specialized expertise made the waiver beneficial to the U.S. national interest.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 6 peer-reviewed journal articles and 56 citations, indicating significant engagement from the scientific community. The work's national importance was validated by funding and support from prestigious institutions like the NIH and HHMI, satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Arizona 51 days 2025-04-15
The petitioner proposes to continue her research in molecular biology focusing on how cellular mechanisms regulate the transition from quiescence to senescence. This work aims to advance therapeutic strategies for age-related conditions such as Alzheimer’s, dementia, and cancer treatment. The endeavor seeks to improve public health outcomes by providing a deeper understanding of cellular aging mechanisms.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-15
The petitioner proposes to develop and implement advanced synthetic biology and genetic engineering techniques to precisely control gene expression and cellular behavior in mammalian cells. Her work aims to enhance therapeutic applications and biotechnological advancements to address critical healthcare challenges, specifically rising cancer rates in the U.S.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 388 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist